Cheryl D. Ng

Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Validation of a Herpes Zoster Conceptual Model on Quality of Life in East Asia.

Validation of a Herpes Zoster Conceptual Model on Quality of Life in East Asia.

Journal: Value in health regional issues
Published: September 26, 2025

Predictive model of public health impact of herpes zoster vaccination and related costs for adults aged ≥50 years in Republic of Korea.

Predictive model of public health impact of herpes zoster vaccination and related costs for adults aged ≥50 years in Republic of Korea.

Journal: Human vaccines & immunotherapeutics
Published: September 26, 2025

Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab.

Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab.

Journal: The journal of prevention of Alzheimer's disease
Published: October 01, 2024

Correction: Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older.

Correction: Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older.

Journal: PharmacoEconomics - open
Published: July 17, 2024

Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study.

Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study.

Journal: Human vaccines & immunotherapeutics
Published: May 28, 2024

Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older.

Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older.

Journal: PharmacoEconomics - open
Published: March 04, 2024

Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada.

Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada.

Journal: BMC health services research
Published: November 21, 2023

Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review.

Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review.

Journal: Human vaccines & immunotherapeutics
Published: March 14, 2023

Public health impact of herpes zoster vaccination on older adults in Hong Kong.

Public health impact of herpes zoster vaccination on older adults in Hong Kong.

Journal: Human vaccines & immunotherapeutics
Published: February 28, 2023

Lifetime risk of herpes zoster in the population of Beijing, China.

Lifetime risk of herpes zoster in the population of Beijing, China.

Journal: Public health in practice (Oxford, England)
Published: August 12, 2022

Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults.

Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults.

Journal: Dermatology and therapy
Published: February 24, 2022

Quantitative means for differentiating renal obstruction by analysing renography by compartmental modelling of renal fluid flow rate.

Quantitative means for differentiating renal obstruction by analysing renography by compartmental modelling of renal fluid flow rate.

Journal: Nuclear medicine communications
Published: April 28, 2016
Showing 1-12 of 13

Last Updated: 09/26/2026